Amrize vs CRH
CRH is the larger business, with $37.45bn of revenue in fiscal 2025 against $11.81bn for Amrize (3.2 times as much). CRH grew faster (5.3% against 0.9%). Amrize kept more of each dollar of sales as profit: a net margin of 10.0% against 10.0%. Amrize carries less debt relative to equity (40.1% against 73.5%).
| Latest fiscal year | AmrizeAMRZ, 2025 | CRHCRH, 2025 |
|---|---|---|
| Revenue | $11.81bn | $37.45bn |
| Revenue growth | 0.9% | 5.3% |
| Net income | $1.19bn | $3.75bn |
| Operating margin | 16.1% | 14.5% |
| Net margin | 10.0% | 10.0% |
| Return on equity | 10.3% | 16.5% |
| Free cash flow | $1.42bn | $2.91bn |
| Cash | $1.92bn | $4.10bn |
| Total debt | $5.27bn | $17.65bn |
| Debt to equity | 40.1% | 73.5% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | $1.18bn |
| Employees | — | 83,032 |
| Market value | $22.73bn | $62.46bn |
| Price vs our value range | Within our value range | Within our value range |
| Moat score | — | — |
| Insider trades, 12 months | 0 buys, 0 sales | 2 buys, 1 sales |